Help Desk for Oncologists | CAR T-Cell Treatment | Colorectal Cancer, Cancer Information Highlights, 02/15/2023

National Cancer Institute

Having trouble viewing this email? View it as a Web page.

Bookmark and Share

Cancer Information Highlights
From the National Cancer Institute
Updating you about cancer causes, prevention, screening, treatment, coping, and more
New from NCI
Help Desk Helps Oncologists Treat People with a Rare Leukemia
  An NCI-funded clinical trial has shown that treatment-related early deaths among people with a rare leukemia can be greatly reduced. How did they do it? In part, by starting a help desk staffed by experts in treating this cancer.
CAR T-Cell Therapies Designed to Overcome Key Limitations
SET THIS ALT TEXT   Two research teams have developed ways of improving CAR T-cell therapies, including ways to make them effective against solid tumors like pancreatic cancer and melanoma.
Drug Combo Approved for Advanced Colorectal Cancer

The Food and Drug Administration (FDA) approved tucatinib (Tukysa) with trastuzumab (Herceptin) to treat HER2-positive advanced colorectal cancer. The approval was based on the MOUNTAINEER trial, in which nearly 40% of participants’ tumors shrank after receiving the drugs.

FDA Approvals
Elacestrant Dihydrochloride

We’ve added a drug summary for elacestrant dihydrochloride (Orserdu). FDA recently approved this drug to treat breast cancer in certain women and men that is ER positive and HER2 negative, has a mutation in the ESR1 gene, has spread, and has gotten worse after treatment with hormone therapy.
Also of Interest
Pain Management for People with Cancer

Controlling pain is an important part of your cancer treatment plan. Learn how to track your levels of pain and how acupuncture, biofeedback, and physical therapy can help treat it.
Infographic: Benefits of Exercise for People with Cancer

Exercise can help reduce cancer-related symptoms and improve how you feel. This infographic shows the benefits for people living with cancer.
Contact Us for Help

Information specialists at NCI’s Cancer Information Service (CIS), NCI's contact center, are available to help answer your cancer-related questions in English and Spanish. Reach us by phone, chat, or email.